Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Invested Capital (2018 - 2024)

Historic Return on Invested Capital for Autolus Therapeutics (AUTL) over the last 5 years, with Q3 2025 value amounting to 0.91%.

  • Autolus Therapeutics' Return on Invested Capital fell 4800.0% to 0.91% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.91%, marking a year-over-year decrease of 4800.0%. This contributed to the annual value of 0.9% for FY2024, which is 300.0% down from last year.
  • Per Autolus Therapeutics' latest filing, its Return on Invested Capital stood at 0.91% for Q3 2025, which was down 4800.0% from 0.77% recorded in Q2 2025.
  • Autolus Therapeutics' Return on Invested Capital's 5-year high stood at 0.35% during Q2 2024, with a 5-year trough of 1.23% in Q4 2023.
  • For the 4-year period, Autolus Therapeutics' Return on Invested Capital averaged around 0.63%, with its median value being 0.61% (2023).
  • As far as peak fluctuations go, Autolus Therapeutics' Return on Invested Capital tumbled by -6100bps in 2023, and later soared by 6900bps in 2024.
  • Autolus Therapeutics' Return on Invested Capital (Quarter) stood at 0.62% in 2022, then tumbled by -98bps to 1.23% in 2023, then soared by 56bps to 0.54% in 2024, then plummeted by -70bps to 0.91% in 2025.
  • Its last three reported values are 0.91% in Q3 2025, 0.77% for Q2 2025, and 0.68% during Q1 2025.